Cytosorbents Receives $5M In Non-Dilutive Debt Financing From Bridge Bank And Extends Loan Agreement
Amount Raised
$5 Million
Round Type
Debt Financing
Monmouth JunctionManufacturingBiotechnologyHealth CareDescription
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that it has received $5 million in non-dilutive debt financing under the terms of the Fourth Amendment to its Amended and Restated Loan and Security Agreement with Bridge Bank, which provided for a term loan commitment of up to $15 million in aggregate, available for drawdown in tranches of $5 million each at the discretion of CytoSorbents and subject to certain financial requirements. Separately, on December 29, 2022, the two parties entered into the Fifth Amendment to the Amended and Restated Loan and Security Agreement, extending the drawdown period on the remaining $10 million loan commitment from December 31, 2022 to March 1, 2023, subject to certain requirements.
Quick answer
CytoSorbents Corporation raised $5 Million in a Debt Financing round, dated December 29, 2022. CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States.
- How much did CytoSorbents Corporation raise?
- CytoSorbents Corporation raised $5 Million in a Debt Financing round on December 29, 2022.
- What does CytoSorbents Corporation do?
- CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.
- Where is CytoSorbents Corporation based and how big is it?
- CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States. Fundz records about 201 employees.
- Who are the decision-makers at CytoSorbents Corporation?
- Fundz holds 1 contact at CytoSorbents Corporation, including the CEO . Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as CytoSorbents Corporation that raised within 45 days of this round, from Fundz verified event records.
- Tioga Cardiovascular raised $30M (Series C) on February 9, 2023.
- Tioga Cardiovascular raised $16M on February 7, 2023.
- Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
- PBS Biotech raised $22M (Funding Round) on January 9, 2023.
- MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
- Endovia Health Sciences, Inc. raised $4M (Seed) on December 27, 2022.
Who to call at CytoSorbents Corporation, and when
A new round usually means CytoSorbents Corporation is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CytoSorbents Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CytoSorbents Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CytoSorbents Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CytoSorbents Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CytoSorbents Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.